| ||
Name: n-{4-[2-(1-cyclopropylpiperidin-4-yl)-4-(3-{[(2,5-difluorophenyl)sulfonyl]amino}-2-fluorophenyl)-1,3-thiazol-5-yl]pyridin-2-yl}acetamide | ||
Formula: C30 H28 F3 N5 O3 S2 | ||
Weight: 627.700 | ||
SMILES: "CC(=O)Nc1cc(ccn1)c2sc(nc2c3cccc(N[S](=O)(=O)c4cc(F)ccc4F)c3F)C5CCN(CC5)C6CC6" | ||
Spacial conformation based on PDB 4cqe |
RESIDUE CQE 71 CONECT F18 1 C13 CONECT C13 3 F18 C14 C12 CONECT C14 3 C13 C15 H14 CONECT C15 3 C14 C16 H15 CONECT C16 3 C15 F19 C17 CONECT F19 1 C16 CONECT C17 3 C16 C12 H17 CONECT C12 3 C13 C17 S9 CONECT S9 4 C12 O10 O11 N8 CONECT O10 1 S9 CONECT O11 1 S9 CONECT N8 3 S9 C5 H8 CONECT C5 3 N8 C6 C4 CONECT C6 3 C5 F7 C1 CONECT F7 1 C6 CONECT C4 3 C5 C3 H4 CONECT C3 3 C4 C2 H3 CONECT C2 3 C3 C1 H2 CONECT C1 3 C6 C2 C20 CONECT C20 3 C1 N21 C24 CONECT N21 2 C20 C22 CONECT C22 3 N21 C25 S23 CONECT C25 4 C22 C30 C26 H25 CONECT C30 4 C25 C29 H301 H302 CONECT C29 4 C30 N28 H291 H292 CONECT C26 4 C25 C27 H261 H262 CONECT C27 4 C26 N28 H271 H272 CONECT N28 3 C29 C27 C37 CONECT C37 4 N28 C38 C39 H37 CONECT C38 4 C37 C39 H381 H382 CONECT C39 4 C37 C38 H391 H392 CONECT S23 2 C22 C24 CONECT C24 3 C20 S23 C31 CONECT C31 3 C24 C36 C32 CONECT C36 3 C31 C35 H36 CONECT C32 3 C31 C33 H32 CONECT C33 3 C32 N34 H33 CONECT N34 2 C33 C35 CONECT C35 3 C36 N34 N40 CONECT N40 3 C35 C41 H40 CONECT C41 3 N40 O42 C43 CONECT O42 1 C41 CONECT C43 4 C41 H431 H432 H433 CONECT H14 1 C14 CONECT H15 1 C15 CONECT H17 1 C17 CONECT H8 1 N8 CONECT H4 1 C4 CONECT H3 1 C3 CONECT H2 1 C2 CONECT H25 1 C25 CONECT H301 1 C30 CONECT H302 1 C30 CONECT H261 1 C26 CONECT H262 1 C26 CONECT H291 1 C29 CONECT H292 1 C29 CONECT H271 1 C27 CONECT H272 1 C27 CONECT H37 1 C37 CONECT H381 1 C38 CONECT H382 1 C38 CONECT H391 1 C39 CONECT H392 1 C39 CONECT H36 1 C36 CONECT H32 1 C32 CONECT H33 1 C33 CONECT H40 1 N40 CONECT H431 1 C43 CONECT H432 1 C43 CONECT H433 1 C43 END HET CQE 71 HETNAM CQE N-{4-[2-(1-cyclopropylpiperidin-4-yl)-4-(3-{[(2,5-diflu HETNAM 2 CQE orophenyl)sulfonyl]amino}-2-fluorophenyl)-1,3-thiazol-5 HETNAM 3 CQE -yl]pyridin-2-yl}acetamide FORMUL CQE C30 H28 F3 N5 O3 S2
This OCA
MONOMER page uses Jmol, developed by the Jmol Development Team (color reference)
|